Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
14.9M
-
Shares change
-
+125K
-
Total reported value, excl. options
-
$69.7M
-
Value change
-
+$407K
-
Put/Call ratio
-
0
-
Number of buys
-
27
-
Number of sells
-
-30
-
Price
-
$4.69
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q1 2024
78 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2024.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.9M shares
of 55M outstanding shares and own 27.02% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4.7M shares), Polar Capital Holdings Plc (1.58M shares), VANGUARD GROUP INC (1.45M shares), BlackRock Inc. (1.35M shares), Parkman Healthcare Partners LLC (917K shares), Uniplan Investment Counsel, Inc. (700K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (581K shares), SVB WEALTH LLC (515K shares), GEODE CAPITAL MANAGEMENT, LLC (514K shares), and STATE STREET CORP (428K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.